Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events
Clinical trial NCT04279470 · COMPLETED
Trial details
- NCT number
- NCT04279470
- Sponsor
- Groupe Hospitalier Pitie-Salpetriere
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-01
- Primary completion
- 2023-01-01
- Enrollment
- 100000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.